Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication of data supporting the effective use of its high-density microarray patch ...
The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...
Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...
The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...
Campbell says this change is similar to another bill working its way through the Iowa House. That bill bans vaccines from ...
News Nation on MSN12d
Multiple states pushing to ban or restrict mRNA vaccinesThe “Make America Healthy Again” commission is reviewing certain vaccines as some states push to restrict the use of COVID-19 ...
Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback